Science
An experimental treatment doubles the one-year survival rate for pancreatic cancer, one of the deadliest cancers, a new study reports.The drug, called elaglusib, targets the protective mesh that pancreatic tumors build around themselves, helping immune molecules and chemotherapy…
Skywatchers are in for a treat as the Northern Lights are predicted to grace the…
Nine Mexican government agencies were hacked in an artificial intelligence (AI)-driven cyberattack between December 2025…
New theoretical research suggests that black holes may never completely evaporate, contradicting Stephen Hawking’s infamous…
There is a serious crisis in cosmology. Different measurements give different values for the rate…
Over the past 10,000 years, natural selection has contributed to the evolution of nearly 500…
A new study of Norwegian lobsters adds to a growing body of evidence that these…
